跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOMETASONE SANDOZ NASAL SPRAY 0.05% - HSA Drug Approval Details
Approvals
/
HSA
/
MOMETASONE SANDOZ NASAL SPRAY 0.05%
Approved
THERAPEUTIC
MOMETASONE SANDOZ NASAL SPRAY 0.05%
Lek Pharmaceuticals d.d.
🇸🇬 Health Sciences Authority
Approval Date
Sep 7, 2017
Approval ID
c47ec5dbbc5eb597
Company
Lek Pharmaceuticals d.d.
Type
Therapeutic
Approval Details
Approval Id
c47ec5dbbc5eb597
Drug Name
MOMETASONE SANDOZ NASAL SPRAY 0.05%
Product Name
MOMETASONE SANDOZ NASAL SPRAY 0.05%
Approval Number
SIN15328P
Approval Date
2017-09-07
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Licence Holder
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SPRAY, SUSPENSION
Route Of Administration
NASAL
Atc Code
R01AD09
Atc Item Name
mometasone
Pharma Manufacturer Name
SANDOZ SINGAPORE PTE. LTD.
Company Detail Path
/organization/sandoz-singapore-pte-ltd
Active Ingredients
Mometasone furoate monohydrate 51.731ug eqv to Mometasone furoate
50ug per actuation
MOMETASONE FUROATE MONOHYDRATE 51.731 MCG EQV TO MOMETASONE FUROATE
50 MCG PER ACTUATION
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 7, 2017
Approval ID
c47ec5dbbc5eb597
Type
Therapeutic
Back to HSA Approvals